PharmaBoardroom

Belgium Takes Measures To Avoid Medicine Shortages During The…

On 8 April 2020, the Belgian federal agency for medicines and health products (‘FAMHP’) adopted a consolidated version of its decision (the…

Mouloud Boukhachab – Head of Africa Middle-East &…

Pierre Fabre’s recently appointed head for Africa, the Middle East and Turkey, Mouloud Boukhachab, outlines his career trajectory, having worked and…

Robert Matsuk – President, Glenmark North America

Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US - including a manufacturing facility…

Stéphane De Wit – Head, Department of Infectious Diseases,…

Professor Stéphane De Wit, head of the Department of Infectious Diseases at St Pierre University Hospital outlines Belgium’s approach to tackling…

Roman Grunt – CEO, Quinta Analytica, Czech Republic

Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country…

Cell & Gene Therapy Manufacturing: Critical Challenges,…

Deloitte's Omkar Kawalekar, Hussain Mooraj, and Amit Agarwal examine the evolution and future of cell and gene therapy manufacturing and the areas in…

New Czech Republic Pharma Report April 2020 Out Now

PharmaBoardroom's latest report: Healthcare & Life Sciences Review: Czech Republic is available for download now. Home to a USD 3.38…

Brazil Pharma News Roundup April 2020

Below we highlight recent news in Brazilian pharma, including the impact of coronavirus as well as legal and regulatory updates. Proposal…

Management in the Age of Confinement

With the global coronavirus pandemic still ongoing and teleworking having become the new normal, pharma executives from across the world are giving us…